Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection-Reference-Cited by-同舟云学术

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection

Published:2007 Issue:4 Volume:110 Page:723-730
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hwang Rosa F.,Gonzalez-Angulo Ana M.,Yi Min,Buchholz Thomas A.,Meric-Bernstam Funda,Kuerer Henry M.,Babiera Gildy V.,Tereffe Welela,Liu Diane D.,Hunt Kelly K.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer

2. The Sentinel Node in Breast Cancer — A Multicenter Validation Study

3. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients

4. Relapse and Morbidity in Patients Undergoing Sentinel Lymph Node Biopsy Alone or With Axillary Dissection for Breast Cancer

5. Morbidity After Sentinel Lymph Node Biopsy in Primary Breast Cancer: Results From a Randomized Controlled Trial

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could axillary lymph node dissection be omitted in the mastectomy patient with tumor positive sentinel node?;Frontiers in Oncology;2023-06-22

2. Axillary management for early invasive breast cancer patients: Who will truly benefit?;Frontiers in Oncology;2022-08-15

3. Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial;Annals of Surgical Oncology;2022-05-12

4. The validity and clinical utility of axillary ultrasonography-guided fine needle aspiration biopsy in detection of nodal metastasis in early-stage breast cancer patients: a retrospective single-center experience;Turkish Journal of Medical Sciences;2022-01-01

5. Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?;Annals of Surgical Oncology;2021-11-05